BioCentury | Aug 10, 2018
Financial News
SQZ raises $72M series C
...an oversubscribed, untranched series C round. New investors Everblue, Illumina Ventures, Invus, Orient Life and Viva Ventures Biotech Group...
Products & Solutions
About Biocentury
Contact
Privacy & Legal
- Follow Us
